FR2404633A1 - Cyanocarboxamidines et quinazolines et leur procede de fabrication - Google Patents
Cyanocarboxamidines et quinazolines et leur procede de fabricationInfo
- Publication number
- FR2404633A1 FR2404633A1 FR7827628A FR7827628A FR2404633A1 FR 2404633 A1 FR2404633 A1 FR 2404633A1 FR 7827628 A FR7827628 A FR 7827628A FR 7827628 A FR7827628 A FR 7827628A FR 2404633 A1 FR2404633 A1 FR 2404633A1
- Authority
- FR
- France
- Prior art keywords
- cyanocarboxamidines
- quinazolines
- manufacturing process
- cyanocarboxamidine
- halohydrate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
- C07D271/113—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/21—Radicals derived from sulfur analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Abstract
L'invention concerne des cyanocarboxamidines et des quinazolines et leur procédé de fabrication. Les cyanocarboxamidines de l'invention sont obtenues en traitant les urées ou thiourées correspondantes avec un agent d'alkylation pour obtenir l'intermédiaire halohydrate correspondant, à faire réagir ce dernier avec de la cyanamide et les quinazolines de l'invention sont obtenues en cyclisant une cyanocarboxamidine ainsi obtenue. Les composés de l'invention sont utiles comme intermédiaires dans d'autres synthèses chimiques
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US05/838,417 US4138561A (en) | 1977-09-30 | 1977-09-30 | Cyanocarboxamidines and quinazoline process |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2404633A1 true FR2404633A1 (fr) | 1979-04-27 |
FR2404633B1 FR2404633B1 (fr) | 1983-05-13 |
Family
ID=25277044
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7827628A Granted FR2404633A1 (fr) | 1977-09-30 | 1978-09-27 | Cyanocarboxamidines et quinazolines et leur procede de fabrication |
Country Status (13)
Country | Link |
---|---|
US (1) | US4138561A (fr) |
JP (1) | JPS5459292A (fr) |
BE (1) | BE870763A (fr) |
CA (1) | CA1121816A (fr) |
CH (1) | CH641172A5 (fr) |
DK (1) | DK429378A (fr) |
FR (1) | FR2404633A1 (fr) |
GB (1) | GB2036001B (fr) |
IE (1) | IE47569B1 (fr) |
IT (1) | IT1107496B (fr) |
NL (1) | NL7809799A (fr) |
SE (1) | SE7904690L (fr) |
WO (1) | WO1979000166A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2381046A1 (fr) * | 1977-02-22 | 1978-09-15 | Bristol Myers Co | Quinazoline et medicaments en contenant |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI57751C (fi) * | 1977-10-25 | 1980-10-10 | Fermion Oy | Foerfarande foer framstaellning av 6,7-dimetoxi- eller 6,7,8-trimetoxi-4-amino-2-(4-substituerade-piperazin-1-yl)-kinazoliner med blodtryckssaenkande verkan |
EP0022481A1 (fr) * | 1979-06-21 | 1981-01-21 | Mitsubishi Yuka Pharmaceutical Co., Ltd. | Dérivés de la 5,6-alcoylènepyrimidine, procédés pour leur préparation et préparations pharmaceutiques |
DE3014353A1 (de) * | 1980-04-15 | 1982-01-21 | Bayer Ag, 5090 Leverkusen | Trisubstituierte cyanguanidine, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide |
JPS5791987A (en) * | 1980-11-26 | 1982-06-08 | Sankyo Co Ltd | Aminoquinazoline derivative and its preparation |
US4367335A (en) * | 1981-08-03 | 1983-01-04 | Mead Johnson & Company | Thiazolidinylalkylene piperazine derivatives |
DE3336409A1 (de) * | 1983-10-06 | 1985-04-18 | Ludwig Heumann & Co GmbH, 8500 Nürnberg | Chinazolinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE3375395D1 (en) * | 1983-11-22 | 1988-02-25 | Heumann Ludwig & Co Gmbh | Process for the preparation of 4-amino-6,7-dimethoxy-2-(4-(furoyl-2)-piperazin-1-yl)-quinazoline and its physiologically acceptable salt |
US4713382A (en) * | 1985-05-30 | 1987-12-15 | Syntex (U.S.A.) Inc. | N-phenyl-4-phenyl-1-piperazinecarboxamidines and related compounds as antiarrhythmic agents |
AT384218B (de) * | 1985-12-04 | 1987-10-12 | Gerot Pharmazeutika | Verfahren zur herstellung von neuen chinazolin-derivaten |
YU70890A (en) * | 1989-04-21 | 1992-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for obtaining quinazoline derivatives |
CA2077252C (fr) * | 1992-08-31 | 2001-04-10 | Khashayar Karimian | Methodes de fabrication d'urees et de guanidines et composes intermediaires servant a ces syntheses |
US5776962A (en) * | 1994-08-03 | 1998-07-07 | Cell Pathways, Inc. | Lactone compounds for treating patient with precancerous lesions |
US5696159A (en) * | 1994-08-03 | 1997-12-09 | Cell Pathways, Inc. | Lactone compounds for treating patients with precancerous lesions |
US6262059B1 (en) | 1995-06-07 | 2001-07-17 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with quinazoline derivatives |
US5874440A (en) * | 1995-06-07 | 1999-02-23 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl pyrimidinone derivatives |
US6200980B1 (en) | 1995-06-07 | 2001-03-13 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl purinone derivatives |
US6060477A (en) * | 1995-06-07 | 2000-05-09 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl cycloamino pyrimidinone derivatives |
US6046216A (en) * | 1995-06-07 | 2000-04-04 | Cell Pathways, Inc. | Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives |
US6046206A (en) * | 1995-06-07 | 2000-04-04 | Cell Pathways, Inc. | Method of treating a patient having a precancerous lesions with amide quinazoline derivatives |
US6232312B1 (en) | 1995-06-07 | 2001-05-15 | Cell Pathways, Inc. | Method for treating patient having precancerous lesions with a combination of pyrimidopyrimidine derivatives and esters and amides of substituted indenyl acetic acides |
CA2238283C (fr) * | 1997-05-30 | 2002-08-20 | Cell Pathways, Inc. | Methode d'identification de composes visant a inhiber les lesions neoplasiques, compositions pharmaceutiques a prtir de ces composes et compositions pour traiter les lesions neoplasiques |
US5858694A (en) * | 1997-05-30 | 1999-01-12 | Cell Pathways, Inc. | Method for identifying compounds for inhibition of cancerous lesions |
US5852035A (en) * | 1997-12-12 | 1998-12-22 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to substituted N- arylmethyl and heterocyclmethyl-1H-pyrazolo (3,4-B) quinolin-4-amines |
US6046199A (en) * | 1998-01-14 | 2000-04-04 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with tetracyclic pyrido[3,4-B]indole derivatives |
US6410584B1 (en) * | 1998-01-14 | 2002-06-25 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells with indole derivatives |
US5942520A (en) * | 1998-01-27 | 1999-08-24 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells by exposure to substituted N-cycloalkylmethyl-1-H-pyrazolo (3,4-B) quinolone-4 amines |
US6313294B1 (en) | 1998-02-04 | 2001-11-06 | Development Center For Biotechnology | Process for preparing amides |
US5990117A (en) * | 1998-04-15 | 1999-11-23 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to quinazoline derivatives |
US6180629B1 (en) | 1998-08-14 | 2001-01-30 | Cell Pathways, Inc. | [4,5]-Fused-1,3-disubstituted-1,2-diazine-6-one derivatives with nitrogen containing substitutents in position one for the treatment of neoplasia |
US6268372B1 (en) | 1998-09-11 | 2001-07-31 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,9-disubstituted purin-6-ones |
US6124303A (en) * | 1998-09-11 | 2000-09-26 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 9-substituted 2-(2-N-aloxyphenyl) purin-6-ones |
US6200771B1 (en) | 1998-10-15 | 2001-03-13 | Cell Pathways, Inc. | Method of using a novel phosphodiesterase in pharmaceutical screeing to identify compounds for treatment of neoplasia |
US6130053A (en) * | 1999-08-03 | 2000-10-10 | Cell Pathways, Inc. | Method for selecting compounds for inhibition of neoplastic lesions |
US6133271A (en) * | 1998-11-19 | 2000-10-17 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure thienopyrimidine derivatives |
US6187779B1 (en) | 1998-11-20 | 2001-02-13 | Cell Pathways, Inc. | Method for inhibiting neoplastic cells and related conditions by exposure to 2,8-disubstituted quinazoline derivatives |
US6369092B1 (en) | 1998-11-23 | 2002-04-09 | Cell Pathways, Inc. | Method for treating neoplasia by exposure to substituted benzimidazole derivatives |
US6034099A (en) * | 1998-11-24 | 2000-03-07 | Cell Pathways, Inc. | Method for inhibiting neoplastic lesions by administering 4-(arylmethylene)- 2, 3- dihydro-pyrazol-3-ones |
US6486155B1 (en) | 1998-11-24 | 2002-11-26 | Cell Pathways Inc | Method of inhibiting neoplastic cells with isoquinoline derivatives |
US6077842A (en) * | 1998-11-24 | 2000-06-20 | Cell Pathways, Inc. | Method of inhibiting neoplastic cells with pyrazolopyridylpyridazinone derivatives |
US6025394A (en) | 1999-01-29 | 2000-02-15 | Cell Pathways, Inc. | Method for treating patients with acne by administering substituted sulfonyl indenyl acetic acids, amides and alcohols |
US6020379A (en) * | 1999-02-19 | 2000-02-01 | Cell Pathways, Inc. | Position 7 substituted indenyl-3-acetic acid derivatives and amides thereof for the treatment of neoplasia |
US6555547B1 (en) | 2000-02-28 | 2003-04-29 | Cell Pathways, Inc. | Method for treating a patient with neoplasia by treatment with a vinca alkaloid derivative |
US6569638B1 (en) | 2000-03-03 | 2003-05-27 | Cell Pathways, Inc | Method for screening compounds for the treatment of neoplasia |
US20070086958A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Formation of medically useful gels comprising microporous particles and methods of use |
US20070087061A1 (en) * | 2005-10-14 | 2007-04-19 | Medafor, Incorporated | Method and composition for creating and/or activating a platelet-rich gel by contact with a porous particulate material, for use in wound care, tissue adhesion, or as a matrix for delivery of therapeutic components |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3935213A (en) * | 1973-12-05 | 1976-01-27 | Pfizer Inc. | Process for hypotensive 4-amino-2-(piperazin-1-yl) quinazoline derivatives |
-
1977
- 1977-09-30 US US05/838,417 patent/US4138561A/en not_active Expired - Lifetime
-
1978
- 1978-09-18 WO PCT/US1978/000083 patent/WO1979000166A1/fr unknown
- 1978-09-18 CH CH511879A patent/CH641172A5/de not_active IP Right Cessation
- 1978-09-18 GB GB7906214A patent/GB2036001B/en not_active Expired
- 1978-09-22 CA CA000311878A patent/CA1121816A/fr not_active Expired
- 1978-09-26 BE BE190708A patent/BE870763A/fr not_active IP Right Cessation
- 1978-09-27 DK DK429378A patent/DK429378A/da not_active Application Discontinuation
- 1978-09-27 FR FR7827628A patent/FR2404633A1/fr active Granted
- 1978-09-27 NL NL7809799A patent/NL7809799A/xx unknown
- 1978-09-29 IE IE1958/78A patent/IE47569B1/en unknown
- 1978-09-29 JP JP11930778A patent/JPS5459292A/ja active Pending
- 1978-09-29 IT IT51318/78A patent/IT1107496B/it active
-
1979
- 1979-05-29 SE SE7904690A patent/SE7904690L/xx unknown
Non-Patent Citations (1)
Title |
---|
EXBK/70 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2381046A1 (fr) * | 1977-02-22 | 1978-09-15 | Bristol Myers Co | Quinazoline et medicaments en contenant |
Also Published As
Publication number | Publication date |
---|---|
IE47569B1 (en) | 1984-05-02 |
JPS5459292A (fr) | 1979-05-12 |
IT1107496B (it) | 1985-11-25 |
CA1121816A (fr) | 1982-04-13 |
US4138561A (en) | 1979-02-06 |
NL7809799A (nl) | 1979-04-03 |
IE781958L (en) | 1979-03-30 |
IT7851318A0 (it) | 1978-09-29 |
DK429378A (da) | 1979-03-31 |
CH641172A5 (de) | 1984-02-15 |
WO1979000166A1 (fr) | 1979-04-05 |
GB2036001A (en) | 1980-06-25 |
SE7904690L (sv) | 1979-05-29 |
FR2404633B1 (fr) | 1983-05-13 |
GB2036001B (en) | 1982-07-07 |
BE870763A (fr) | 1979-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2404633A1 (fr) | Cyanocarboxamidines et quinazolines et leur procede de fabrication | |
FR2361902A1 (fr) | Derives de la glucosamine et leur procede de fabrication | |
BR8200553A (pt) | Processo de obtencao de compostos com grupos isocianuricos monomeros ou polimeros por ciclotrimerizacao catalitica de isocianatos;processo de obtencao de poliisocianato-poliisocianurato;por ciclotrimerizacao de di isocianato alifatico ou cicloalifatico e compostos contendo grupos isocianuricos | |
FR2393818A1 (fr) | Procede de preparation de polyimides cycliques lineaires | |
FI882418A (fi) | Menetelmä valmistaa terapeuttisesti aktiivisia syklisiä amiinijohdannaisia | |
BE890862A (fr) | Procede de recuit continu pour la producton de tole d'acier doux laminee a froid | |
FR2426051A1 (fr) | Nouvelles 3-aryloxy-substitue-aminopyridines et procedes pour leur production | |
FR2386532A1 (fr) | Nouvelles (thio)urees substituees, leur procede de preparation et leur application comme insecticides. | |
DE68923103T2 (de) | Verfahren zur Herstellung von 2-Amino-4,6-dichloro-Pyrimidin. | |
BE852583A (fr) | Procede de fabrication directe d'acier brut | |
IT1079052B (it) | Procedimento per la produzione di acido 8 ammino 1 nafto 3,6 disolfonico | |
FR2388844A1 (fr) | Procede d'obtention en discontinu de polymeres derives de para-phenylenediamine | |
ES8106126A1 (es) | Procedimiento para obtencion de intermediarios para la pro- duccion de penicilinas | |
FR2463781B1 (fr) | Procede pour la production de polypropylene ayant une aptitude a l'etirage amelioree | |
FR2358387A1 (fr) | Nouveaux oxime-carbamates de cetones fluorees, leur procede de preparation et leur application comme insecticides, acaricides et nematicides | |
FR2406647A1 (fr) | Procede de preparation de liants deposables a la cathode | |
FR2374314A1 (fr) | Procede de production d'acide cyanurique a partir d'uree et nouveau produit ainsi obtenu | |
BR9603728A (pt) | Processo para a produção de um composto | |
FR2405313A1 (fr) | Procede de production de files de polyamide a auto-plissement ou auto-ondulation et nouveaux produits ainsi obtenus | |
FR2381741A1 (fr) | 1-arylamino-2,4-dinitronaphtalenes, leur procede de preparation et leur application comme pesticides | |
EP0248220A3 (fr) | Procédé de préparation d'urées cycliques | |
BE894424A (fr) | Procede de fabrication de tole ou de feuillard d'acier d'emboutissage lamine a froid | |
EP0171811A3 (fr) | Production d'acétal amide bicyclique | |
US4245102A (en) | Processes for the preparation of tetramisole | |
CA1135270A (fr) | Procedes d'obtention de tetramisole et nouveaux intermediaires |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |